UnitedHealth Group Incorporated· UNH
🇺🇸 US · LargeSP500NYSE
- Price
- $397.14
- Day
- -0.95%
- Mkt Cap
- $360.66B
- 52W Range
- $255.97 – $461.62
- Volume
- 4.83M
- Beta
- 0.62
Find a company by name or ticker and open its page
Snapshot of fundamentals, performance, and 5D scores.
Business fundamentals and company information
Recent price action and historical returns
How the business makes money, by product and geography
Five lenses on the stock. Click any card to dive deeper.
How to read these dimensions
The five dimensions are independent lenses on a company, not a single combined score. Read them together rather than in isolation: where one dimension scores differently from the others is often the most useful place to focus your own research. Each score is built from rules and weights you can adjust, so treat them as a transparent starting point for your analysis, not a recommendation to buy or sell.
Recent news headlines and analyst price-target moves
Insurers Have Already Told Wall Street Which Advantage Plans Die on December 31. Members Are the Last to Know, and the Letter Isn’t Due Until October 2.
Insurers spent the summer telling Wall Street exactly which Medicare Advantage plans are disappearing on December 31. Enrolled members get a letter in October, a closing enrollment window in December, and a rare legal protection most will never realize they have.
Buy 3 Ideal September Dividend Dogs Out Of Barron's 58 August Picks
Barron's August 24th, 2026 stock picks highlight 47 dividend payers, with Danone, Gap, and Kohl's emerging as "safer" ideal candidates. Top ten picks by yield project 15.4% to 44.59% gains by September 2027, with an average net gain of 23.6% and risk/volatility 14% below the market. Dividend dog strategy identifies contrarian opportunities, emphasizing price pull-backs and yield improvement for both new and existing positions.
UnitedHealth Is Trouncing the Market in 2026. Is the Stock Still a Buy?
Headwinds weighed on UnitedHealth's earnings last year, but the company today is better managing challenges. UnitedHealth recently lifted its full-year earnings forecast.
UnitedHealth Stock Rises 39% in 6 Months: Should Investors Still Buy?
UNH's 39% six-month rally reflects improving medical costs, stronger earnings estimates and a sharper focus on profitable businesses.
Is UnitedHealth Finally Turning the Corner After a Tough 2025?
UNH is showing signs of recovery as medical costs improve, Optum gains momentum and 2026 earnings guidance rises.